Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Martín-Torregrosa

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Semergen|December 21, 2024
Bullous impetigo due to methicillin-resistant StaphylococcusaureusM Mansilla-Polo, D Martín-Torregrosa
Semergen|November 21, 2024
Generalized pustular lesionsM Mansilla-Polo, D Martín-Torregrosa
Semergen|March 30, 2024
Atypical targetoid lesionsM Mansilla-Polo, D Martín-Torregrosa, C Abril-Pérez
Semergen|June 26, 2024
Tirbanibulin ointment: A new effective and safe treatment of recalcitrant viral wartsM Mansilla-Polo, C Abril-Pérez, D Martín-Torregrosa
Actas Dermo-Sifiliograficas|October 10, 2024
[Translated article] Use of Anifrolumab in Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus, and Other Autoimmune DermatosesD Martín-Torregrosa, M Mansilla-Polo, D Morgado-Carrasco
Semergen|December 17, 2024
Delusional parasitosis (Ekbom's syndrome)M Mansilla-Polo, D Martín-Torregrosa, R Botella-Estrada
Actas Dermo-Sifiliograficas|June 25, 2025
[Translated article] RF - New Treatments in Cutaneous Lupus Erythematosus: Current and Future PerspectivesM Mansilla-Polo, D Martín-Torregrosa, R Botella-Estrada
Actas Dermo-Sifiliograficas|April 9, 2025
RF - New Treatments in Cutaneous Lupus Erythematosus: Current and Future PerspectivesM Mansilla-Polo, D Martín-Torregrosa, R Botella-Estrada
Actas Dermo-Sifiliograficas|July 7, 2024
Use of Anifrolumab in Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus, and Other Autoimmune DermatosesD Martín-Torregrosa, M Mansilla-Polo, D Morgado-Carrasco
Actas Dermo-Sifiliograficas|December 7, 2023
Cutaneous Sarcoidosis after Platelet-Rich Plasma Injections and Permanent Eyebrow Make-UpD Martín-Torregrosa, M Mansilla-Polo, M Rodríguez-Serna, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Semergen|December 21, 2024
Bullous impetigo due to methicillin-resistant StaphylococcusaureusM Mansilla-Polo, D Martín-Torregrosa
Semergen|November 21, 2024
Generalized pustular lesionsM Mansilla-Polo, D Martín-Torregrosa
Semergen|March 30, 2024
Atypical targetoid lesionsM Mansilla-Polo, D Martín-Torregrosa, C Abril-Pérez
Semergen|June 26, 2024
Tirbanibulin ointment: A new effective and safe treatment of recalcitrant viral wartsM Mansilla-Polo, C Abril-Pérez, D Martín-Torregrosa
Actas Dermo-Sifiliograficas|October 10, 2024
[Translated article] Use of Anifrolumab in Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus, and Other Autoimmune DermatosesD Martín-Torregrosa, M Mansilla-Polo, D Morgado-Carrasco
Semergen|December 17, 2024
Delusional parasitosis (Ekbom's syndrome)M Mansilla-Polo, D Martín-Torregrosa, R Botella-Estrada
Actas Dermo-Sifiliograficas|June 25, 2025
[Translated article] RF - New Treatments in Cutaneous Lupus Erythematosus: Current and Future PerspectivesM Mansilla-Polo, D Martín-Torregrosa, R Botella-Estrada
Actas Dermo-Sifiliograficas|April 9, 2025
RF - New Treatments in Cutaneous Lupus Erythematosus: Current and Future PerspectivesM Mansilla-Polo, D Martín-Torregrosa, R Botella-Estrada
Actas Dermo-Sifiliograficas|July 7, 2024
Use of Anifrolumab in Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus, and Other Autoimmune DermatosesD Martín-Torregrosa, M Mansilla-Polo, D Morgado-Carrasco
Actas Dermo-Sifiliograficas|December 7, 2023
Cutaneous Sarcoidosis after Platelet-Rich Plasma Injections and Permanent Eyebrow Make-UpD Martín-Torregrosa, M Mansilla-Polo, M Rodríguez-Serna, et al.
Pageof 2